Taking a huge step towards the goal of elimination of cervical cancer, India is getting ready to roll out its indigenous quadrivalent human papillomavirus (HPV) vaccine named Cervavac as a part of the universal immunization program. This began with the National Technical Advisory Group on
No takes yet. Share an insight, caveat, or question.
Jayraj et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: